Predictions
Barrick Gold Corp
Start price
Target price
Perf. (%)
€19.58
06.12.20
06.12.20
€22.00
0.57%
08.12.20
08.12.20
Future proof or reliable business model
Higher EBIT margin than peer group
positive Cash Flow expected
Good rating
Barrick Gold Corp
Start price
Target price
Perf. (%)
€19.58
06.12.20
06.12.20
€22.00
0.57%
08.12.20
08.12.20
Future proof or reliable business model
Higher EBIT margin than peer group
positive Cash Flow expected
Good rating
Moderna Inc.
Start price
Target price
Perf. (%)
€127.18
05.12.20
05.12.20
-
05.12.21
05.12.21
18.07%
10.02.21
10.02.21
Significant cyclical dependencies
Higher risks for its business
American Airlines Group Inc.
Start price
Target price
Perf. (%)
€13.68
05.12.20
05.12.20
-
05.12.21
05.12.21
28.84%
24.02.21
24.02.21
Higher risks for its business
Below average Management
American Airlines Group Inc.
Start price
Target price
Perf. (%)
€13.68
05.12.20
05.12.20
-
05.12.21
05.12.21
28.84%
24.02.21
24.02.21
Higher risks for its business
Below average Management
American Airlines Group Inc.
Start price
Target price
Perf. (%)
€13.68
05.12.20
05.12.20
-
05.12.21
05.12.21
28.84%
24.02.21
24.02.21
Higher risks for its business
Below average Management
Occidental Petroleum Corp.
Start price
Target price
Perf. (%)
€15.30
05.12.20
05.12.20
€20.00
05.12.21
05.12.21
70.94%
06.12.21
06.12.21
Could be very worthwhile Investment >20% year
Trevena Inc.
Start price
Target price
Perf. (%)
€49.08
04.12.20
04.12.20
€55.00
28.04.21
28.04.21
23.84%
09.02.21
09.02.21
Could be very worthwhile Investment >20% year
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€3.58
04.12.20
04.12.20
-
04.12.21
04.12.21
282.12%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bio Path Holdings
Start price
Target price
Perf. (%)
€2.80
04.12.20
04.12.20
-
04.12.21
04.12.21
-81.43%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Porsche Automobil Holding SE
Start price
Target price
Perf. (%)
€55.96
04.12.20
04.12.20
-
04.12.21
04.12.21
8.33%
05.02.21
05.02.21
Top 10 in its market
Well known brand
Future proof or reliable business model
Capable Management
Ralph Lauren A
Start price
Target price
Perf. (%)
€80.18
03.12.20
03.12.20
-
03.12.21
03.12.21
27.96%
04.12.21
04.12.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Well known brand
Best Buy Co.
Start price
Target price
Perf. (%)
€87.65
03.12.20
03.12.20
-
03.12.21
03.12.21
6.42%
24.02.21
24.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
Well known brand
Coca-Cola Co.
Start price
Target price
Perf. (%)
€43.09
03.12.20
03.12.20
-
03.12.21
03.12.21
10.93%
04.12.21
04.12.21
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Future proof or reliable business model
Coca-Cola Co.
Start price
Target price
Perf. (%)
€43.09
03.12.20
03.12.20
-
03.12.21
03.12.21
10.93%
04.12.21
04.12.21
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Future proof or reliable business model
Ever-Glory International
Start price
Target price
Perf. (%)
€6.05
03.12.20
03.12.20
-
-55.70%
10.12.20
10.12.20
Risky Investment
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€11.72
02.12.20
02.12.20
-
02.12.21
02.12.21
-39.70%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Salesforce.com
Start price
Target price
Perf. (%)
€193.98
02.12.20
02.12.20
-
02.12.21
02.12.21
6.12%
17.02.21
17.02.21
Could be worthwhile Investment >10% per year
Very capable Management
Market Leader or Top 3
Very Future proof/growth oriented business model
MSCI Inc. A
Start price
Target price
Perf. (%)
€343.60
01.12.20
01.12.20
-
01.12.21
01.12.21
1.83%
06.03.21
06.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected